Dupilumab is safe and efficacious for the treatment of atopic dermatitis for 3 years among pediatric patients aged 6 months to 11 years.

This NIHR Collection brings together major studies on the prevention and treatment of childhood eczema. It finds that many ...

Atopic dermatitis (eczema) is a chronic skin condition involving patches of dry, inflamed, and itchy skin. It can affect both children and adults. Various treatments can help manage symptoms.

Biologic treatment for atopic dermatitis appeared to improve growth trajectories for younger children, a trial analysis ...

ATOPIC dermatitis (AD) is a chronic inflammatory skin condition that significantly impacts patients’ quality of life. It is ...

Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...

Contrary to some commonly held beliefs, current research shows that cutting out certain foods makes little difference in ...

Atopic dermatitis disease activity remained mild after patients treated with Vtama cream 1% achieved nearly 80 consecutive ...

Discussions centered on mitigating the financial burden of pediatric atopic dermatitis through financial aid programs and enhancing support for young patients to independently manage their condition ...

Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...

Prenatal exposure to fine particulate matter (PM2.5) at levels above 65 µg/m³ was associated with a sharp rise in atopic ...

The reduction in itch was the greatest contributor to quality-of-life improvement for adolescents and adults with atopic ...